Basic Information
OXYCONTIN® NEO CONTROLLED-RELEASE TABLETS 20 MG
TABLET, FILM COATED, EXTENDED RELEASE
Regulatory Information
SIN14885P
October 28, 2015
Prescription Only
Therapeutic
ORAL
August 10, 2023
May 30, 2025
XN02AA05
Company Information
MUNDIPHARMA PHARMACEUTICALS PTE. LTD.
MUNDIPHARMA PHARMACEUTICALS PTE. LTD.
Active Ingredients
Strength: 20 mg
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to opioids and to any of the constituents or in any situation where opioids are contraindicated, acute respiratory depression, cor pulmonale, cardiac arrhythmias, severe bronchial asthma, chronic obstructive airways disease, paralytic ileus, suspected surgical abdomen, moderate to severe hepatic impairment, severe renal impairment (creatinine clearance < 10ml/min), delayed gastric emptying, acute alcoholism, brain tumor, increased cerebrospinal or intracranial pressure, head injury, severe CNS depression, convulsive disorders, delirium tremens, hypercarbia, concurrent administration of monoamine oxidase inhibitors or within 2 weeks of discontinuation of their use. Not recommended for pre-operative use or for the first 24 hours post-operatively. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Indication Information
**Indications and usage** _**OxyContin® Neo**_ is indicated for the management of pain severe enough to require daily, around the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. _Limitations of Use_ - Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve _**OxyContin® Neo**_ for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - _**OxyContin® Neo**_ is not indicated as an as-needed (prn) analgesic